I was really thrilled to be part of the ACoP 2025 preconference “From Pharmacometrics to Registration: Accelerating a Medicine’s Path to Patients,” chaired by the fabulous Lourdes Cucurull-Sanchez and Sandra Visser!
I facilitated 4 debates interspersed throughout the day, under the moniker “Pharmacometrics Pfisticuffs” – while the topics may be serious, the format was creative, lively, and surprising 🤩
- Does Pharmacometrics accelerate or slow down a medicine’s path to patients? Bill Denney versus Jin Jin
- Is Clinical Pharmacology an enabler or a barrier for Pharmacometrics? Nieves Velez de Mendizabal versus Jackson Burton
- Is Biostatistics a more important partner for drug development than Pharmacometrics, or are they equal partners? James Rogers versus Richard Franzese
- Is AIML or QSP saving the day for Pharmacometrics? Mohamed Shahin versus Monica Susilo
